Abnormal cholinergic neurotransmission has been suggested to occur in psychiatric illness. Therefore, this study investigated cholinergic muscarinic receptors in the anterior cingulate cortex (ACC) of schizophrenia, bipolar disorder and major depression disorder (n ¼ 15 per group). We used quantitative autoradiography to measure ]pirenzepine binding in subjects with major depression relative to control subjects. We also detected a significant effect of suicide on [ 3 H]pirenzepine binding in the ACC in subjects who died as a result of suicide relative to those who did not, which was more evident in patients with schizophrenia. A significant effect of the onset of the disease was also observed that was more evident in patients with bipolar disorder. The study provides evidence of decreased muscarinic receptor density in the ACC in schizophrenia but no evidence for significant changes in these receptors in the bipolar and major depression groups. The changes observed in schizophrenia may contribute to dysfunctional ACC neural circuits.
INTRODUCTION
Evidence suggests that muscarinic acetylcholine receptors may play an important role in the neural mechanisms underlying the pathophysiology of mood disorders and schizophrenia. Considerable evidence suggests increased cholinergic neurotransmission in bipolar mania and major depression disorders (Thakore and Dinan, 1996; Dilsaver, 1986; Fritze, 1993) . In addition, muscarinic receptorcoupled pertussis toxin-sensitive G proteins have been suggested to be the molecular site for the antimanic therapeutic effects of antibipolar treatments (Avissar and Schreiber, 1991) . Atypical antipsychotic drugs (eg clozapine, olanzapine), which are among the most effective anti-schizophrenia medications available, have strong antimuscarinic properties (Raedler et al, 2000) . Further, studies using post-mortem brain tissue suggest regionspecific changes to muscarinic receptors in schizophrenia. Early studies, using post-mortem tissue from schizophrenia patients, found increased M2/M4 receptor binding in the orbital frontal cortex and putamen (Owen et al, 1981; Watanabe et al, 1983) and decreased binding in frontal, parietal, and temporal cortices (Bennett et al, 1979) . More recently, Dean et al (1996) and Crook et al (2000 Crook et al ( , 2001 found decreased M1/M4 receptor binding in the striatum, hippocampal formation, and prefrontal cortex in schizophrenia. Also, a deficit in cholinergic interneurons, as well as decreased binding to muscarinic M2/M4 receptors, has been suggested to occur in the striatum in schizophrenia (Holt et al, 1999; Crook et al, 1999) .
The anterior cingulate cortex (ACC; Brodmann's area 24) is localized within a gyrus on the media surface of each hemisphere, bordering on the corpus callosum. Neuropathological changes have been reported in the ACC in bipolar disorder, major depression, and schizophrenia (see Knable et al, 2002 , for a review). There is also evidence suggesting that the ACC might be an anatomical locus of a cholinergic deficiency in schizophrenia. It receives intense cholinergic innervation from a collection of cells in the basal forebrain, the anteromedial sector of the Ch4 cholinergic group of the nucleus basalis of Meynert (Mesulam, 1995) . It is involved in functions (eg cognition, attention) that are modulated by acetylcholine and are deficient in schizophrenia (Hyde and Crook, 2001) . Abnormalities in noncholinergic receptor systems (including glutamate, GABA, and serotonin) that are modulated by acetylcholine have been reported in the ACC in schizophrenia by our group and others (Benes, 2000) . Impairment in excitatory outflow activity of ACC pyramidal neurons has been suggested to occur in schizophrenia (Benes, 2000) , and muscarinic receptors can regulate this activity (Hyde and Crook, 2001) .
Muscarinic receptors of the M1/M4 subtype are localized postsynaptically and are the most abundant in the ACC (Gebhard et al, 1995; Mash et al, 1998) . In the present study, we tested the hypothesis that muscarinic receptor density is altered in the ACC in schizophrenia. We used quantitative autoradiography and the muscarinic antagonist [ 3 H]pirenzepine that binds selectively to M1 and M4 receptors (Flynn and Mash, 1993) . Since considerable evidence suggests increased cholinergic neurotransmission in the pathophysiology of bipolar mania and major depression disorders (Thakore and Dinan, 1996; Dilsaver, 1986; Fritze, 1993) , the present study also tested the hypothesis that muscarinic receptors are altered in the ACC of bipolar and major depression disorders.
MATERIAL AND METHODS

Post-Mortem Brain Tissue
Tissue was collected by the Stanley Foundation Brain Bank, which coded all specimens and screened the brains to exclude neuropathological abnormalities. A detailed description of this collection has been published recently (Torrey et al, 2000) . The sample consisted of 60 cases (15 control, 15 schizophrenia, 15 bipolar, and 15 major depression cases). Demographic details are given in Table 1 . Diagnoses of schizophrenia, bipolar disorder, and major depression were made according to the criteria of the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders. Eight frozen sections were provided from the ACC (Brodmann's area 24) from each case. Inspection of Nissl stained sections indicated that the material comprised area 24a and 24b, together with a small contribution from area 32 and/or 33 and the subjacent callosal white matter (Vogt et al, 1995) . Experiments were performed blind to all clinical details.
Autoradiography
All the sections were processed simultaneously to minimize experimental variance. The sections were preincubated for 15 min at room temperature in 22 mM HEPES (pH 7.4), and then incubated for 90 min at room temperature in the same buffer containing 10 nM ligand was measured in 10 ml aliquots taken from the incubation mixture. After incubation, the sections were rinsed three times (4 min each) in ice-cold buffer with a final dipping in ice-cold distilled water and air-dried. After the assay, sections were exposed to 
Quantitative Analysis of Autoradiographic Images
Autoradiographs were developed at room temperature in Kodak X-ray developer (4 min) and exposed to cold tap water (15 s), Kodak X-ray fixer (4 min), cold tap water (10 min), and room temperature air to dry. For the confirmation of anatomical structures, sections were stained with cresyl violet after the development of the autoradiographs. Section images on the film were then superimposed on the stained sections and observed under an Olympus BX-50 microscope to determine the distribution of each ligand among the cortical layers.
Quantification analysis of the resulting autoradiographic images was performed by using a computer-assisted image analysis system (Multi Analyst, BIO-RAD, USA), connected to a GS-690 Imaging Densitometre. 
Statistical Analysis
One-way analysis of variance (ANOVA) was used to compare the levels of radioligand binding in different ACC cortical compartments (upper and lower laminae) per study cohort. ANOVA, followed by least statistical significance (LSD) post hoc tests, was used to compare the mean age, post-mortem interval (PMI), onset of the disease, freezer storage time, and pH value between the four diagnostic groups.
For continuous descriptive variables (PMI, age, estimated lifetime exposure to neuroleptics, age of illness onset, illness duration, brain pH, brain weight and freezer storage time), we sought significant Spearman's correlations for the abnormal radioligand binding. Three non-continuous descriptive variables (hemisphere, gender and suicide) were used as grouping variables with t-tests to evaluate their effects on abnormal radioligand binding.
Separate one-way analyses of covariance (ANCOVA), controlling for age, suicide, and PMI, were performed within each cortical compartment (upper and lower laminae). The LSD post hoc test was used for comparisons of the main effects of diagnosis on radioligand binding between the four groups. All tests were performed using the SPSS statistical package. 
RESULTS
Laminar Distribution of [ 3 H]pirenzepine Binding in the ACC
Effects of Continuous and Non-continuous Confounding Variables
The mean age, PMI, pH, and brain weight did not differ between the groups studied. One-way ANOVA revealed significant differences in freezer storage time between the four diagnostic groups (F ¼ 5.353, df ¼ 3,56, p ¼ 0.003). More specifically, the mean freezer time was significantly shorter in the control group in comparison to the bipolar and schizophrenia groups (p ¼ 0.002 and 0.002, respectively), whereas it was significantly longer in the bipolar and Muscarinic receptors in psychiatric disorders K Zavitsanou et al p ¼ 0.031) and a significant correlation between pH andH]pirenzepine (the concentration of ligand used in the present study) labels 62.5% of M1 receptors and 18.5% of M4 receptors (Flynn and Mash, 1993) . Therefore, this study provides information about the distribution and density of M1/M4 muscarinic receptors in the ACC of patients with schizophrenia, bipolar, and major depression as well as normal controls. We observed a higher density of M1/M4 receptors in the upper laminae compared to lower laminae in all groups studied. This characteristic cortical lamination pattern of M1/M4 receptors has been previously described (Piggott et al, 2002) .
Although considerable evidence suggests abnormal cholinergic neurotransmission in the pathophysiology of bipolar mania and major depression, the results from this study do not support this notion, with no significant difference of M1/M4 receptor density observed between bipolar, major depression, and controls. In the depression group, muscarinic receptor density appeared to be affected by the duration of the illness, as the longer the duration of the illness, the higher the receptor density. In the bipolar group, there was a significant negative correlation between the density of receptors and the onset of the disease, suggesting that the earlier the age at onset, the lower the number of receptors. This may indicate that a younger age of onset of bipolar disorder is a factor affecting negatively on M1/M4 receptors in the ACC.
In this study, schizophrenia patients who had committed suicide had a higher density of M1/M4 receptors in the ACC than patients who died from other causes. A previous study suggested a 47% elevation of muscarinic receptors, in frontal cortical areas from cases who had committed suicide, compared to cases who did not (Meyerson et al, 1982) . It is known that among patients with schizophrenia and schizoaffective disorders, as many as 40% attempt suicide at some stage in their lives and approximately 10% die from suicide (Meltzer and Okayli, 1995) . The relationship between depression and suicide is unclear. In this study, no significant differences were observed between suicide and nonsuicide victims in both bipolar and major depression groups. Although the incidence of clinical depression in suicides is well documented, a statistical collation of such studies revealed that 12-64% of suicide victims were previously diagnosed as clinically depressed (Whitlock, 1977) . Therefore, although suicide is often a consequence of depression, it seems possible that the muscarinic receptor alterations observed in the schizophrenia cases who committed suicide in this study, may not be exclusively associated with depression but with more complex neurochemical interactions associated with other pathophysiological states of the disease. Future studies that examine neurotransmitter receptor abnormalities in schizophrenia should therefore take into account patient's histories regarding suicidal behavior. Nevertheless, further studies, with larger numbers of schizophrenia cases who committed suicide, are required to delineate the relationship of muscarinic receptors to schizophrenia and suicide.
The present study revealed a significant decrease in M1/ M4 receptor density in both upper and lower layers in the schizophrenia group as compared to the control group. In agreement with our results, Dean et al (1996) and Crook et al (2000 Crook et al ( , 2001 found decreased [ 3 H]pirenzepine binding to muscarinic M1/M4 receptors in the striatum, hippocampal formation, and prefrontal cortex in schizophrenia patients. A potential confounding factor in all studies in schizophrenia is the possible effects of antipsychotic medication. In the present study, the decrease in M1/M4 muscarinic receptor binding does not seem to be secondary to previous antipsychotic medication exposure since we found no correlation between [ 3 H]pirenzepine binding and final recorded antipsychotic drug dose in the schizophrenia group. In addition, animal studies suggest that typical or atypical antipsychotic drugs tended to increase or have no effect on the density of [ 3 H]pirenzepine-labelled receptors in rat frontal cortex .
Recent studies support abnormal neural circuitry in the ACC in schizophrenia. Studies by Francine Benes have indicated a loss of interneurons and increased GABA A receptor densities in the upper layers of the ACC in schizophrenia (see Benes, 2000 for a review). We have recently reported increased glutamate NMDA and AMPA receptor densities and decreased serotonin 5HT 2A receptors in the ACC of schizophrenia . Importantly, all these systems are modulated by acetylcholine. The topographic co-occurance of cholinergic and other neurotransmitter receptor changes may signify important functional interactions in the ACC in schizophrenia. Further studies, combining neuroanatomical and binding techniques, are required to delineate these interactions as well as the relationship between cholinergic and other receptor system abnormalities in the ACC in schizophrenia.
The present study provides support for the presence of a deficit in M1/M4 receptors in the ACC in schizophrenia. The ACC asserts a fundamental role in normal cognition and controls the attention system that appears to function abnormally in schizophrenia (Posner et al, 1988) . Since acetylcholine plays an important role in various domains of cognition including attention, it seems reasonable to suggest that changes in the muscarinic receptor system in the ACC in schizophrenia may be involved in the pathology of the disorder, particularly in relation to attentional and cognitive deficits. Most of the atypical antipsychotic drugs (eg clozapine, olanzapine) used for the treatment of both positive and negative symptoms of schizophrenia with less incidence of extrapyramidal side effects have been shown to possess muscarinic antagonistic properties (Raedler et al, 2000) . Therefore, abnormalities in the muscarinic receptor system in the ACC in schizophrenia may also be involved in the pharmacotherapy of the disease.
